A U.S. House panel sent letters to four e-cigarette companies asking them to stop all print, broadcast and digital advertising of their products in the United States.
The number of Americans sickened by a severe vaping-related illness continues to increase, according to a U.S. health official speaking at a Congressional hearing.
U.S. health officials said there are 530 confirmed and probable cases and seven deaths from severe lung-related illnesses tied to vaping, and there are no signs that the outbreak is easing.
The Trump administration announced plans to remove all flavored e-cigarettes from store shelves in a widening crackdown on vaping, as officials warned that sweet flavors had drawn millions of children into nicotine addiction.
Health investigators are casting a wide net to understand what is sickening hundreds of vapers across the United States and still have not ruled out any product on the market.
The U.S. Department of Health and Human Services will offer states more than $1.8 billion in new funding to fight the opioid epidemic.
In a late-stage study, Genentech’s flu drug Xofluza showed significant efficacy as a preventative treatment.
The U.S. Centers for Disease Control and Prevention identified 193 potential cases of severe lung illness tied to vaping in 22 states as of Aug. 22, including one adult in Illinois who died after being hospitalized.
The U.S. FDA gave Nabriva Therapeutics a thumbs-up for the company’s oral and intravenous formulations of Xenleta (lefamulin) to treat community-acquired bacterial pneumonia in adults.
Innovations in diabetes care go beyond new therapeutic classes. Pharmaceutical companies are continuing to invest in new technology to help improve diabetes treatment and patient adherence with progress ranging from artificial pancreases to smart insulin pens and pumps.